BTSG vs HCA
BrightSpring Health Services, Inc. and HCA Healthcare, Inc., side by side — 4 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BTSG | HCA |
|---|---|---|
| Revenue | $12.9B | $75.6B |
| Net income | $190.7M | $6.8B |
| Gross margin | 11.8% | · |
| Net margin | 1.5% | 10.3% |
| Return on equity | 10.8% | · |
| Diluted EPS | $0.87 | $28.33 |
| Dividend / share | · | $2.88 |
| Payout ratio | · | 10.0% |
| Free cash flow | $394.7M | $7.7B |
| Equity | $1.9B | $-6.0B |
| Net debt / equity | 1.29× | · |
| Current ratio | 1.57× | 0.97× |
| Revenue CAGR 5y | · | 8.0% |
| Profit CAGR 5y | · | 12.6% |
HCA bills 5.9× the revenue of BTSG, and keeps more of each dollar of revenue as profit (10.3% against 1.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
4 years side by side
| Fiscal year | BTSG | HCA |
|---|---|---|
| FY2025 | $12.9B | $75.6B |
| FY2024 | $10.1B | $70.6B |
| FY2023 | $7.7B | $65.0B |
| FY2022 | $7.7B | $60.2B |
Bottom line
| Fiscal year | BTSG | HCA |
|---|---|---|
| FY2025 | $190.7M | $6.8B |
| FY2024 | $-18.1M | $5.8B |
| FY2023 | $-154.6M | $5.2B |
| FY2022 | $-53.9M | $5.6B |
Standard deviation, each side
BTSG's net margin has been more volatile than HCA's over the 4 comparable fiscal years — 1.3 percentage points of standard deviation against 0.8.
4 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
HCA led in net margin in every one of the 4 comparable fiscal years — a structural lead, not a recent swing.
4 of 16 comparable fiscal years — a year missing data on either side is not counted.